Lifestyle
- Regular exercise
- Avoid alcohol
- Adequate hydration
Aspartat-Aminotransferase · ASAT · GOT · SGOT
AST quantifies the enzyme activity involved in amino acid metabolism, reflecting liver and muscle cell integrity.
Reference ranges may vary slightly by laboratory; fasting not required.
Aspartate aminotransferase (AST), also known as glutamate oxaloacetate transaminase (GOT), is an enzyme that plays a critical role in amino acid metabolism by catalyzing the transfer of an amino group from aspartate to alpha-ketoglutarate. This process results in the formation of oxaloacetate and glutamate, which are pivotal in the citric acid cycle and energy production. Clinically, AST is an important biomarker for liver health, as it is released into the bloodstream when liver cells are damaged. Elevated AST levels can indicate liver damage or disease, such as hepatitis, cirrhosis, or liver fibrosis. It is also found in heart and muscle tissues, so its elevation can reflect myocardial infarction or muscle injury. In the context of athletic performance and biohacking, AST levels are monitored to assess muscle recovery and liver function, especially in individuals undertaking intense physical training or using performance-enhancing substances. However, interpreting AST levels requires caution as they can be influenced by factors such as recent exercise, medication, or alcohol consumption. Therefore, it is essential to consider these confounders and ensure consistent testing conditions for accurate assessment.
Klinische Bedeutung
Elevated AST levels indicate potential liver damage or disease, myocardial infarction, or muscle injury. Reduced levels are generally not clinically significant but may reflect malnutrition or vitamin B6 deficiency.
Progressively rising AST values suggest worsening liver function or muscle injury; re-test in 4 weeks if elevated.
Falling AST values may indicate recovery from liver or muscle injury.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any supplementation, especially if liver disease is suspected.
Levels may vary throughout the day; morning tests are preferred for consistency.
Testing Frequency
Annually for healthy adults, more frequently if liver disease is suspected.
Current research suggests that reference ranges for AST (GOT) may vary significantly across populations and methodologies, leading to potential misinterpretations of liver function. Researchers have not yet established optimal thresholds for AST in predicting liver fibrosis or cirrhosis, particularly in diverse clinical contexts. Additionally, unanswered clinical questions remain regarding the role of AST in distinguishing between different liver pathologies and its utility in monitoring treatment responses in chronic liver diseases.
429
Total Citations
17
Human/RCT
2.5
Avg. Influence
2025
Latest
Researchers conducted a meta-analysis to identify biomarkers associated with the severity of COVID-19. They found that ASAT levels were significantly higher in severe cases compared to non-severe cases, indicating a potential role in prognostic risk stratification. Other biomarkers like C-reactive protein and interleukin-6 were also linked to increased severity of the disease.
Researchers discussed the use of serum enzyme levels, including ASAT, for diagnosing alcohol-related organ damage. They noted that while elevated ASAT levels indicate liver injury, a combination of tests is needed for accurate diagnosis.
This study assessed the incidence of hypoxic hepatitis in patients with cardiogenic shock. Researchers found that elevated ASAT levels were a strong predictor of 30-day mortality, with patients experiencing hypoxic hepatitis having significantly higher mortality rates. ASAT was identified as the most reliable laboratory predictor of outcomes in this patient population.
Researchers investigated the effects of ursodeoxycholic acid (UDCA) on liver function in patients with hepatic sarcoidosis. They found that ASAT levels improved significantly in patients treated with UDCA compared to those receiving no treatment or corticosteroids. The study supports the potential use of UDCA in symptomatic patients with liver involvement.
This study evaluated clinical and biochemical signs in patients with GM1 gangliosidosis. Researchers found increased ASAT concentrations in many patients, suggesting its potential role in screening for this genetic disorder.
Researchers reviewed methodologies for determining aspartate aminotransferase (ASAT) and proposed a unifying reference system to improve interlaboratory compatibility of ASAT results. They emphasized the need for stable reference materials to standardize ASAT measurements.
This study analyzed clinical and laboratory findings in elderly patients with leptospirosis. Researchers observed elevated ASAT levels in patients, with severe forms of the disease associated with higher mortality rates.
This study proposed a protocol for an enhanced cardiac enzyme profile to improve the diagnosis of myocardial injury. Researchers highlighted the usefulness of ASAT and the ASAT/ALAT ratio in evaluating cardiac conditions, particularly when testing occurs later after symptom onset. The protocol aims to streamline enzyme testing for better diagnostic outcomes.
Researchers compared self-reported alcohol consumption questionnaires with laboratory markers for alcohol dependence. They found that ASAT levels, along with other markers, had low sensitivity for diagnosing alcoholism, although they showed high specificity. This study suggests that while alcohol markers can support diagnosis, they may not be reliable screening tools in general hospitals.
Researchers assessed the stability of capillary blood samples for various analytes, including ASAT, stored in Microtainers. They found that ASAT results from capillary samples showed acceptable agreement with serum samples, suggesting that capillary blood could be a viable alternative for health screenings.
Research publications about AST (GOT) over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer